Tag: ISC 2025
Minimally invasive surgery appears beneficial in deep and lobar intracranial haemorrhages
The MIND study—presented for the first time at this year’s International Stroke Conference (ISC; 5–7 February, Los Angeles, USA)—has revealed the potential benefits of...
Viz.ai announces two new studies indicating stroke solutions’ benefit regarding patient...
Viz.ai recently announced new data supporting advancements in neurovascular care, with two studies—both presented at the 2025 International Stroke Conference (ISC; 5–7 February, Los...
DiVERT Stroke study uncovers sex-based disparities in post-stroke cardiac care
New findings from the DiVERT Stroke clinical study show that women spent less time in the hospital, saw fewer referrals to cardiology and were...
Alteplase may be effective up to 24 hours after initial stroke...
The clot-dissolving medication alteplase can improve stroke patients’ recovery by more than 50% when given up to 24 hours after the beginning of an ischaemic...
Hyperfine reports growing evidence supporting use of Swoop system images in...
Hyperfine has announced the presentation of two studies at the 2025 International Stroke Conference (ISC; 5–7 February, Los Angeles, USA) that provide evidence supporting the...
Ischaemic stroke outcomes with Vivistim paired VNS therapy highlighted at ISC...
Microtransponder has announced that neurosurgeon Ronald Benitez (Atlantic Brain and Spine, Morristown, USA) presented safety and outcomes data from the largest, real-world cohort of...
‘Chasing’ EVT with tenecteplase injection may lead to improved 90-day stroke...
Removing a blood clot from a large brain artery via endovascular therapy (EVT), then injecting the clot-dissolving drug tenecteplase into the artery, has resulted...
ESCAPE-MeVO and DISCOUNT trials find no clinical benefit with thrombectomy in...
Two randomised trials presented at the International Stroke Conference (ISC; 5–7 February, Los Angeles, USA) have indicated that mechanical thrombectomy treatments confer no advantages...
Arsenal Medical completes enrolment of initial EMBO-02 study cohort
Arsenal Medical has announced the complete enrolment of an initial cohort of 10 patients in the EMBO-02 clinical study evaluating NeoCast for the treatment...
Electrical brain stimulation fails to boost post-stroke motor recovery in multicentre...
Mild electrical brain stimulation—specifically, transcranial direct current stimulation (tDCS)—did not further improve motor recovery in stroke survivors in a multicentre study presented as late-breaking...
Revalesio announces new analyses from Phase 2 RESCUE study assessing RNS60...
Revalesio has announced new analyses of the completed Phase 2 RESCUE clinical trial evaluating its drug candidate RNS60 in acute ischaemic stroke that demonstrate...
Terumo Neuro promotes fully integrated, comprehensive stroke portfolio at ISC 2025
Terumo Neuro has announced that the company is showcasing its comprehensive and streamlined portfolio of stroke solutions at booth number 522 at the International Stroke...
Siemens Healthineers showcases mobile stroke unit and digital solutions at ISC...
Siemens Healthineers has announced in a press release that it is showcasing its new mobile solution to support stroke diagnosis, designed to speed up...
Vena Medical gains US FDA Breakthrough Device designation for MicroAngioscope device
Vena Medical has been granted Breakthrough Device designation from the US Food and Drug Administration (FDA) for its MicroAngioscope, marking what the company describes...
Stroke thrombectomy safe but not found to reduce disability versus standard...
Removing a clot blocking a medium- or small-sized artery in the brain via a mechanical thrombectomy procedure proved to be a safe treatment for...
New data presented at ISC 2025 further validate treatment impact of...
Brainomix will be unveiling a series of new studies this week at the International Stroke Conference (ISC; 5–7 February, Los Angeles, USA), further validating...
Remedy announces upcoming presentation of “groundbreaking” CHARM study data at ISC...
Remedy Pharmaceuticals has announced that three speaker presentations reporting efficacy data from both the Phase 2 GAMES-RP and Phase 3 CHARM studies on its...
Blood test could help clinicians “rapidly” distinguish between haemorrhagic and ischaemic...
A blood test may have the ability to rapidly distinguish haemorrhagic strokes (brain bleeds) from ischaemic (clot-caused) strokes, even before patients with stroke symptoms...
Combined embolisation-drainage approach could be “transformational” next step in endovascular cSDH...
The past 18 months have seen a radical shift in clinical evidence supporting the role of middle meningeal artery embolisation (MMAe) within subdural haematoma...
Joseph P Caruso appointed to Brain Aneurysm Foundation’s board of directors
The Brain Aneurysm Foundation (BAF) has announced the appointment of Joseph P Caruso to its board of directors, with Caruso commencing a three-year term...
